Balyasny Asset Management’s Natural Health Trends NHTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-12,659
Closed -$241K 2029
2018
Q1
$241K Sell
12,659
-3,600
-22% -$61K ﹤0.01% 1694
2017
Q4
$247K Buy
16,259
+6,410
+65% +$121K ﹤0.01% 1821
2017
Q3
$235K Buy
+9,849
New +$225K ﹤0.01% 1636
2016
Q2
Sell
-7,400
Closed -$245K 1355
2016
Q1
$245K Sell
7,400
-2,620
-26% -$71.1K ﹤0.01% 1064
2015
Q4
$336K Buy
10,020
+2,120
+27% +$93.3K ﹤0.01% 935
2015
Q3
$258K Buy
7,900
+955
+14% +$28.9K ﹤0.01% 951
2015
Q2
$288K Buy
+6,945
New +$206K ﹤0.01% 962

Other funds holding NHTC

Balyasny Asset Management's NHTC Position: Q2 2018 in Review

Balyasny Asset Management sold out of Natural Health Trends (NHTC) in Q2 2018, closing a stake of 12,659 shares — an estimated $241K sold.

Balyasny Asset Management first reported a position in NHTC in Q2 2015 and held it in 7 quarters. The position peaked at $336K in Q4 2015. 69 funds tracked by Wall St. Rank hold NHTC as of Q2 2018.

  • Balyasny Asset Management reported no remaining Natural Health Trends position as of Q2 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 12,659 Natural Health Trends shares in Q2 2018, an estimated $241K.
  • Balyasny Asset Management first reported a position in Natural Health Trends in Q2 2015 and held it in 7 quarters.
  • Balyasny Asset Management's Natural Health Trends position peaked at $336K in Q4 2015.
  • 69 funds tracked by Wall St. Rank held Natural Health Trends as of Q2 2018.

Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.